Back to Search Start Over

Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials.

Authors :
Tanimoto A
Kadoya M
Kawamura Y
Kuwatsuru R
Gokan T
Hirohashi S
Source :
Academic radiology [Acad Radiol] 2002 Aug; Vol. 9 Suppl 2, pp. S457-9.
Publication Year :
2002

Details

Language :
English
ISSN :
1076-6332
Volume :
9 Suppl 2
Database :
MEDLINE
Journal :
Academic radiology
Publication Type :
Academic Journal
Accession number :
12188307
Full Text :
https://doi.org/10.1016/s1076-6332(03)80262-3